Metastatic Bladder Cancer

Also known as: Bladder Cancer, Metastatic

DrugDrug NameDrug Description
DB01248DocetaxelA taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.
DB01229PaclitaxelA taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer.
DrugDrug NameTargetType
DB01248DocetaxelApoptosis regulator Bcl-2target
DB01248DocetaxelTubulin beta-1 chaintarget
DB01248DocetaxelCytochrome P450 3A4enzyme
DB01248DocetaxelCytochrome P450 3A5enzyme
DB01248DocetaxelCytochrome P450 3A7enzyme
DB01248DocetaxelATP-dependent translocase ABCB1transporter
DB01248DocetaxelATP-binding cassette sub-family C member 10transporter
DB01248DocetaxelCytochrome P450 1B1enzyme
DB01248DocetaxelMicrotubule-associated protein 2target
DB01248DocetaxelMicrotubule-associated protein 4target
DB01248DocetaxelMicrotubule-associated protein tautarget
DB01248DocetaxelSolute carrier organic anion transporter family member 1B3transporter
DB01248DocetaxelSolute carrier family 22 member 7transporter
DB01248DocetaxelBroad substrate specificity ATP-binding cassette transporter ABCG2transporter
DB01248DocetaxelATP-binding cassette sub-family C member 2transporter
DB01248DocetaxelMultidrug resistance-associated protein 1transporter
DB01248DocetaxelNuclear receptor subfamily 1 group I member 2target
DB01229PaclitaxelApoptosis regulator Bcl-2target
DB01229PaclitaxelTubulin beta-1 chaintarget
DB01229PaclitaxelCytochrome P450 2C8enzyme
DB01229PaclitaxelCytochrome P450 3A4enzyme
DB01229PaclitaxelCytochrome P450 3A5enzyme
DB01229PaclitaxelCytochrome P450 3A7enzyme
DB01229PaclitaxelBile salt export pumptransporter
DB01229PaclitaxelATP-dependent translocase ABCB1transporter
DB01229PaclitaxelMultidrug resistance-associated protein 1transporter
DB01229PaclitaxelATP-binding cassette sub-family C member 10transporter
DB01229PaclitaxelAromataseenzyme
DB01229PaclitaxelCytochrome P450 1B1enzyme
DB01229PaclitaxelSolute carrier organic anion transporter family member 1B3transporter
DB01229PaclitaxelNuclear receptor subfamily 1 group I member 2target
DB01229PaclitaxelMicrotubule-associated protein 4target
DB01229PaclitaxelMicrotubule-associated protein 2target
DB01229PaclitaxelMicrotubule-associated protein tautarget
DB01229PaclitaxelATP-binding cassette sub-family C member 2transporter
DrugDrug NamePhaseStatusCount
DB11595Atezolizumab1Recruiting1
DB09035Nivolumab1Completed1
DB16409Tiragolumab1Recruiting1
DB11595Atezolizumab1 / 2Active Not Recruiting1
DB11945Avelumab1 / 2Terminated1
DB00515Cisplatin1 / 2Active Not Recruiting1
DB14873Enadenotucirev1 / 2Completed1
DB16168Fluorocyclopentenylcytosine1 / 2Completed1
DB00441Gemcitabine1 / 2Active Not Recruiting1
DB06094Apatorsen2Completed1
DB11595Atezolizumab2Recruiting1
DB11945Avelumab2Terminated1
DB00958Carboplatin2Completed1
DB00958Carboplatin2Terminated1
DB00515Cisplatin2Completed1
DB00515Cisplatin2Terminated1
DB11714Durvalumab2Completed1
DB00441Gemcitabine2Completed1
DB00441Gemcitabine2Terminated1
DB11771Tremelimumab2Completed1
DB15442Trilaciclib2Terminated1